Hospital-based influenza and pneumococcal vaccination: Sutton's law applied to prevention

Infection Control and Hospital Epidemiology

Volumn 21, Issue 11, 2000, Pages 692-699

  Fedson, D S ^a   Houck, P ^a   Bratzler, D ^a  

^a SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; EDITORIAL; HEALTH CARE POLICY; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; PATIENT SELECTION; PREVALENCE; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0033741340     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501716     Document Type: Editorial

References (70)

1. A hospital-based influenza immunization program, 1977-78
2. Influenza vaccine: Delivering the goods
3. Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983
4. Previous hospital care as a risk factor for pneumonia. Implications for immunization with pneumococcal vaccine
5. Previous hospital care and pneumococcal bacteremia. Importance for pneumococcal immunization
6. Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: A review of its rationale and implications
7. Risk factors for acquiring pneumococcal infections
8. Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study
9. Influenza and pneumococcal immunization strategies for physicians
10. Immunization policies and vaccine coverage among adults. The risk for missed opportunities
11. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly
12. Immunizations for healthcare workers and patients in hospitals
13. Pneumococcal immunization: Strategies for implementation
14. Prevention and control of influenza Recommendations of the Immunization Practices Advisory Committee (ACIP)
15. Pneumococcal polysaccharide vaccine Recommendations of the Immunization Practices Advisory Committee (ACIP)
16. Public health burden of vaccine-preventable disease among adults standards of adult immunization practice
17. Adult immunization: A summary report for the National Vaccine Advisory Committee
18. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and Adults
19. Guideline for prevention of nosocomial pneumonia
20. Management advisory - Health care delivery immunization
21. Position paper immunizations
22. Position paper: Immunizations
23. Influenza vaccination in 18 developed countries, 1980-1992
24. Influenza vaccination in 29 developed countries: An update to 1997
25. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996
26. Influenza vaccination: Cost-effectiveness and public policy
27. Cost effectiveness of vaccination against pneumococcal pneumonia: An update
28. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly
29. Clinical effectiveness of influenza vaccination in Manitoba
30. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community
31. The benefits of influenza vaccination for low-, intermediates, and high-risk senior citizens
32. Clinical effectiveness of pneumococcal vaccination: A brief review
33. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease
34. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized placebo-controlled trial
35. Safety of revaccination with pneumococcal polysaccharide vaccine
36. Cost effectiveness of vaccination against pneumococcal bacteremia among elderly people
37. Prevention Medicare influenza vaccine demonstration - Selected states, 1988-1992
38. Evaluation of the effectiveness of immunization delivery methods
39. Prevention Final results Medicare influenza vaccine demonstration - Selected states, 1988-1992
40. Influenza pneumococcal vaccination levels among adults aged >65 years - United States
41. Influenza A among hospital personnel and patients. Implications for recognition, prevention, and control
42. Nosocomial influenza in a general hospital for indigent patients
43. Prevention of nosocomial influenza
44. Outbreak of infection with penicillin-resistant pneumococci
45. Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in The Netherlands
46. Computer reminders to Implement preventive care guidelines for hospitalized patients
47. Pneumococcal vaccine in the hospital. Improved use and Implications for high-risk patients
48. A hospital-based pharmacy intervention program for pneumococcal vaccination
49. Using a vaccine manager to enhance in-hospital vaccine administration
50. A strategy to improve utilization of pneumococcal vaccine
51. Increased utilization of influenza and pneumococcal vaccines in an elderly hospitalized population
52. An effective hospital-based pneumococcal immunization program
53. Achieving the national health objective for influenza immunization. Success of an institution-wide vaccination program
54. Long-term success with the national health objective for influenza vaccination: An institution-wide model
55. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults
56. Improving influenza vaccination rates for high-risk inpatients: A successful for hospital-wide program
57. Hospital-based strategies for improving influenza vaccination rates
58. Missed opportunities for influenza vaccination of Medicare pneumonia inpatients - 12 western states, 1995
59. Use of standing orders programs to increase adult vaccination rates. Recommendations of the Advisory Committee on Immunization Practices
60. Pharmacists as vaccine advocates: Roles in community pharmacies, nursing homes and hospitals
61. Immunogenicity and acceptability of influenza vaccine (V) administered at hospital discharge
62. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia
63. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
64. The old man's friend
65. The economics of hospital infection
66. The fifth evolutionary era in infection control: Interventional epidemiology